Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: a mini review

QJM. 2022 Aug 13;115(8):507-512. doi: 10.1093/qjmed/hcz162.

Abstract

Expression of programmed cell death-1 (PD-1/CD279) on T cells and the ligand of PD-1, programmed death ligand-1 (PD-L1) (CD274/B7-H1) on tumor cells or other immune cells, such as myeloid-derived suppressor cells, are important mechanisms to induce malignant immunosuppression. PD-1/PD-L1 expression on B-cell subsets, as well as their signaling and inhibitory functions in solid tumors will be discussed in this review with the focus on how B cells expressing PD-1/PD-L1 play immunosuppressive roles in tumor progression, aiming to figure out the potential for development of diagnostic tools and new therapies involving this unique group of cells.

Publication types

  • Review

MeSH terms

  • B7-H1 Antigen* / metabolism
  • Humans
  • Immunosuppressive Agents
  • Ligands
  • Neoplasms*
  • Programmed Cell Death 1 Receptor

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor
  • Ligands
  • Immunosuppressive Agents